Senescence-messaging secretome: SMS-ing cellular stress
The DOI matches its Crossref record; 147 of the 147 references it cites were found in a registry or an index.
Abstract
Oncogene-induced cellular senescence constitutes a strong anti-proliferative response, which can be set in motion following either oncogene activation or loss of tumour suppressor signalling. It serves to limit the expansion of early neoplastic cells and as such is a potent cancer-protective response to oncogenic events. Recently emerging evidence points to a crucial role in oncogene-induced cellular senescence for the 'senescence-messaging secretome' or SMS, setting the stage for cross-talk between senescent cells and their environment. How are such signals integrated into a coordinated response and what are the implications of this unexpected finding?
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, the SASP reinforces and spreads senescence in autocrine and paracrine fashions (Acosta et al., 2013; Coppe ´ et al., 2010; Kuilman and Peeper, 2009) and activates immune responses that eliminate senescent cells (Krizhanovsky et al., 2008a; Mun ˜ oz-Espı ´n and Serrano, 2014).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Kuilman and Peeper, 2009
In the citing paper
“Senescent cells secrete a plethora of factors, including pro-inflammatory cytokines and chemokines, growth modulators, angiogenic factors, and matrix metalloproteinases (MMPs), collectively termed the senescent associated secretory phenotype (SASP) or senescence messaging secretome (SMS) (Figure 1; Table 2) (Coppe ´ et al., 2010; Kuilman and Peeper, 2009).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Kuilman and Peeper, 2009
In the citing paper
“OIS or senescence induced by loss of a tumor suppressor was verified in vivo in human and murine preneoplastic lesions (Collado et al., 2005; Gorgoulis and Halazonetis, 2010; Kuilman and Peeper, 2009) and primary or treated neoplasias (Haugstetter et al., 2010).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Kuilman and Peeper, 2009
In the citing paper
“In most studies, senescence is assessed in ex vivo cultures or fresh samples by SAb -gal staining or indirect markers in formalin-fixed tissues”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Kuilman and Peeper, 2009
In the citing paper
“This SASP or senescence messaging secretome (SMS) (Kuilman and Peeper 2009) reflects the non-cell-autonomous functionality of senescent cells and may underpin their in vivo role in the pathophysiology of aging and age-related disorders.”
From Cellular senescence and its effector programs (2014) · cites this paper as Kuilman and Peeper 2009
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“OIS corresponds to a premature form of cellular senescenc”
BackgroundCellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Pleiotropy, natural selection, and the evolution of senescence.
Williams, G. C. (1957) · Evolution · doi:10.1111/j.1558-5646.1957.tb02911.x · Cited by 4,279
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473 · cited 1×
“For instance, in a mouse model of liver carcinoma driven by inducible shRNA-mediated depletion of p53 and HRAS V12 expression, Scott Lowe's laboratory showed that reactivation of p53 in the tumour results in a robust senescence respons”
BackgroundSenescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,379
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 1×
“OIS and replicative senescence share a number of characteristics, including an increase in senescence-associated β-galactosidase (SA-β-GAL) activity and the condensation of individual chromosomes into distinct heterochromatic bodies, called senescence-associated heterochromatic foci (SAHF”
BackgroundBRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Self-citation
Research works printed but not linked: 1
- Gagnon, A. M., Chabot, J., Pardasani, D. & Sorisky, A. Extracellular matrix induced by TGFβ impairs insulin signal transduction in 3T3-L1 preadipose cells. J. Cell Physiol. 175, 370–378 (1998). · doi:10.1002/(sici)1097-4652(199806)175:3<370::aid-jcp15>3.0.co;2-9
Cited by
Items 401–500 of 910
Recent advances in senescence-associated secretory phenotype and osteoporosis
Fan, H., Qiao, Z., Li, J., Shang, G., Shang, C., Chen, S., Leng, Z., Su, H., Kou, H., & Liu, H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e25538 · Cited by 49
“This hypersecretion phenotype is defined as the senescence-associated secretome (SASP)or the senescence-message secretome (SMS) [19], which is one of the main characteristics of senescence [20].”
BackgroundPlacental Senescence and the Two‐Stage Model of Preeclampsia
Sugulle, M., Fiskå, B. S., Jacobsen, D. P., Fjeldstad, H. E., & Staff, A. C. (2024) · American Journal of Reproductive Immunology · doi:10.1111/aji.13904 · Cited by 49
Level of macroautophagy drives senescent keratinocytes into cell death or neoplastic evasion
Deruy, E., Nassour, J., Martin, N., Vercamer, C., Malaquin, N., Bertout, J., Chelli, F., Pourtier, A., Pluquet, O., & Abbadie, C. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.533 · Cited by 38
Soluble M6P/IGF2R Released by TACE Controls Angiogenesis via Blocking Plasminogen Activation
Leksa, V., Loewe, R. P., Binder, B., Schiller, H. B., Eckerstorfer, P., Forster, F., Soler‐Cardona, A., Ondrovičová, G., Kutějová, E., Steinhuber, E., et al. (2011) · Circulation Research · doi:10.1161/circresaha.110.234732 · Cited by 38
Mitochondrial Bioenergetics and Dynamics in Secretion Processes
Martínez, J., Marmisolle, I., Tarallo, D., & Quijano, C. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00319 · Cited by 46
The Role of cGAS-STING in Age-Related Diseases from Mechanisms to Therapies
Zheng, W., Feng, D., Xiong, X., Liao, X., Wang, S., Xu, H., Le, W., Wei, Q., & Yang, L. (2023) · Aging and Disease · doi:10.14336/ad.2023.0117 · Cited by 50
“with autocrine and paracrine signaling, pro-tumorigenic and tumor-suppressive effects, and pro- and antiinflammatory signaling [19].”
BackgroundPòcsfalvi, G., Votta, G., Vincenzo, A. D., Fiume, I., Raj, D. A. A., Marra, G., Stoppelli, M. P., & Iaccarino, I. (2011) · Journal of Proteome Research · doi:10.1021/pr200584y · Cited by 40
The impact of ageing mechanisms on musculoskeletal system diseases in the elderly
Cai, Y., Han, Z., Cheng, H., Li, H., Wang, K., Chen, J., Liu, Z., Xie, Y., Lin, Y., Zhou, S., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1405621 · Cited by 57
“Cellular senescence also exerts biological effects in the local cellular environment or on the entire body, and the sum of various cytokines produced by senescent cells is called the SASP (36).”
BackgroundProgrammed cell senescence: role of IL-6 in the pituitary
Sapochnik, M., Fuertes, M., & ARZT, E. S. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0026 · Cited by 44
Adult Cardiac Stem Cell Aging: A Reversible Stochastic Phenomenon?
Cianflone, E., Torella, M., Chimenti, C., Angelis, A. D., Beltrami, A. P., Urbanek, K., Rota, M., & Torella, D. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/5813147 · Cited by 41
Ni, J., Au, M. T., Kong, H., Wang, X., & Wen, C. (2021) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-021-03385-0 · Cited by 37
“The senescent cells (SnCs) remain viable and metabolically active but secrete a variety of pro-inflammatory cytokines, growth factors, chemokines and proteinases known as the senescence-messaging secretome or senescence-associated secretory phenotype (SASP) [79, 80].”
BackgroundInfluentialA geroscience motivated approach to treat Alzheimer’s disease: Senolytics move to clinical trials
Gonzales, M. M., Krishnamurthy, S., Garbarino, V. R., Daeihagh, A. S., Gillispie, G. J., Deep, G., Craft, S., & Orr, M. E. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111589 · Cited by 38
Age and metastasis – How age influences metastatic spread in cancer. Colorectal cancer as a model
Pretzsch, E., Nieß, H., Bösch, F., Westphalen, C. B., Jacob, S., Neumann, J. H. L., Werner, J., Heinemann, V., & Angele, M. K. (2022) · Cancer Epidemiology · doi:10.1016/j.canep.2022.102112 · Cited by 41
Fibroblast activation and senescence in oral cancer
Prime, S. S., Cirillo, N., Hassona, Y. M., Lambert, D., Paterson, I. C., Mellone, M., Thomas, G. J., James, E. N., & Parkinson, E. K. (2016) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12456 · Cited by 43
Alharbi, K. S., Afzal, O., Altamimi, A. S. A., Almalki, W. H., Kazmi, I. A., Al-Abbasi, F. A., Alzarea, S. I., Makeen, H. A., & Albratty, M. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14471 · Cited by 37
Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?
Martínez-Zubiaurre, I., & Hellevik, T. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01093-5 · Cited by 40
“Soluble SASP elements such as MMPs have been associated with pro-tumorigenic effects from radiation-induced senescent fibroblasts in vitro and in vivo [30, 76, 77].”
BackgroundInfluentialCell dormancy plasticity: quiescence deepens into senescence through a dimmer switch
Fujimaki, K., & Yao, G. (2020) · Physiological Genomics · doi:10.1152/physiolgenomics.00068.2020 · Cited by 43
Beyond cells: The extracellular circulating 20S proteasomes.
Dwivedi, V., Yaniv, K., & Sharon, M. (2020) · Biochimica et Biophysica Acta - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.166041 · Cited by 37
Role of autophagy in lung diseases and ageing
Zhang, Y., Zhang, J., & Fu, Z. (2022) · European Respiratory Review · doi:10.1183/16000617.0134-2022 · Cited by 41
Cellular senescence and neurodegeneration
Holloway, K., Neherin, K., Dam, K. U., & Zhang, H. (2023) · Human Genetics · doi:10.1007/s00439-023-02565-x · Cited by 43
Treatment-induced host-mediated mechanisms reducing the efficacy of antitumor therapies
Daenen, L. G. M., Houthuijzen, J. M., Cirkel, G. A., Roodhart, J. M. L., Shaked, Y., & Voest, E. E. (2013) · Oncogene · doi:10.1038/onc.2013.94 · Cited by 42
Quantitative model of cell cycle arrest and cellular senescence in primary human fibroblasts
Schäuble, S., Klement, K., Marthandan, S., Münch, S., Heiland, I., Schuster, S., Hemmerich, P., & Diekmann, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042150 · Cited by 35
“Furthermore, senescent cells express matrix-degrading proteases and inflammatory chemokines and cytokines, known as the senescencemessaging secretome (SMS) or senescence-associated secretory phenotype (SASP) [17–21].”
BackgroundProgressive lung fibrosis: reprogramming a genetically vulnerable bronchoalveolar epithelium
Bridges, J. P., Vladar, E. K., Kurche, J. S., Krivoi, A., Stancil, I. T., Dobrinskikh, E., Hu, Y., Sasse, S. K., Lee, J. S., Blumhagen, R. Z., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci183836 · Cited by 46
“At a molecular level, senescence is a state of irreversible replicative arrest characterized by markers of DNA damage, cellular hypertrophy, upregulation of lysosomal β -galactosidase, and expression of the cyclin-dependent kinase inhibitors ( CDKN1A and CDKN2A ) (137).”
Hubáčková, S., Krejčíková, K., Bártek, J., & Hodný, Z. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.316869 · Cited by 45
PKCη promotes senescence induced by oxidative stress and chemotherapy
Zurgil, U., Ben-Ari, A., Atias, K., Isakov, N., Apte, R. N., & Livneh, E. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.481 · Cited by 35
Premature expression of a muscle fibrosis axis in chronic HIV infection
Kusko, R. L., Banerjee, C., Long, K. K., Darcy, A., Otis, J. S., Sebastiani, P., Melov, S., Tarnopolsky, M. A., Bhasin, S., & Montano, M. A. (2012) · Skeletal Muscle · doi:10.1186/2044-5040-2-10 · Cited by 34
Rosemblit, C., Datta, J., Lowenfeld, L., Xu, S., Basu, A. B., Kodumudi, K. N., Wiener, D. A., & Czerniecki, B. J. (2018) · Oncotarget · doi:10.18632/oncotarget.25208 · Cited by 39
Carracedo, J., Alique, M., Ramírez-Carracedo, R., Bodega, G., & Ramírez, R. (2018) · Current Vascular Pharmacology · doi:10.2174/1570161116666180820115726 · Cited by 36
Stereotactic Lung Irradiation in Mice Promotes Long-Term Senescence and Lung Injury
Soysouvanh, F., Benadjaoud, M. A., Santos, M. D., Mondini, M., Lavigne, J., Bertho, A., Buard, V., Tarlet, G., Adnot, S., Deutsch, É., et al. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2019.12.039 · Cited by 42
From Development to Aging: The Path to Cellular Senescence
Sacco, A., Belloni, L., & Latella, L. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8071 · Cited by 41
NGAL as a Potential Target in Tumor Microenvironment
Crescenzi, E., Leonardi, A., & Pacifico, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212333 · Cited by 38
“Such phenotype is termed senescence-associated secretory phenotype (SASP) [77] or senescence messaging secretome (SMS) [78].”
BackgroundAge‐related cellular and microstructural changes in the rotator cuff enthesis
Long, Z., Nakagawa, K., Wang, Z., Amadio, P. C., Zhao, C., & Gingery, A. (2021) · Journal of Orthopaedic Research® · doi:10.1002/jor.25211 · Cited by 34
“disease pathologies, including comorbidities, such as metabolic syndrome, which are negatively associated with healing outcomes.(53,54) Additionally another consequence of the increased accumulation of senescent cells is the depletion of stem and progenitor cells.”
BackgroundDrake, L. E., & Macleod, K. F. (2013) · The Journal of Pathology · doi:10.1002/path.4298 · Cited by 34
“Senescent fibroblasts also behave in some ways like CAFs in their ability to induce tumour cell proliferation [22,23] and, conversely, CAFs mimic senescent fibroblasts through expression of the ‘senescent-associated secretory phenotype’ (SASP), which includes pro-inflammatory cytokines, chemokines and proteinases [20,…”
Tan, M. L. M., Parkinson, E. K., Yap, L. F., & Paterson, I. C. (2021) · Scientific Reports · doi:10.1038/s41598-020-79789-8 · Cited by 36
Salamanders: The molecular basis of tissue regeneration and its relevance to human disease
Gómez, C. M. A., & Echeverri, K. (2021) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2020.11.009 · Cited by 40
Biological Aspects of Inflamm-Aging in Childhood Cancer Survivors
Rossi, F., Paola, A. D., Pota, E., Argenziano, M., Pinto, D., Marrapodi, M. M., Leva, C. D., Martino, M. D., & Tortora, C. (2021) · Cancers · doi:10.3390/cancers13194933 · Cited by 39
Gangoda, L., Keerthikumar, S., Fonseka, P., Edgington‐Mitchell, L. E., Ang, C., Ozcitti, C., Bogyo, M. S., Parker, B. S., & Mathivanan, S. (2015) · Oncotarget · doi:10.18632/oncotarget.3579 · Cited by 35
“Within the cellular microenvironment, secreted proteins play a direct role in the regulation of both physiological and pathophysiological processes [8-10].”
BackgroundCD20-Targeting Immunotherapy Promotes Cellular Senescence in B-Cell Lymphoma
Däbritz, J. H. M., Yu, Y., Milanovic, M., Schönlein, M., Rosenfeldt, M. T., Dörr, J. R., Kaufmann, A. M., Dörken, B., & Schmitt, C. A. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0627 · Cited by 37
“Vertical marks indicate the positions of bead clouds corresponding to two major SASP cytokines, i.e., IL6 (red) and IL8 (blue) compared with untreated controls (hatched lines) for different ADR concentrations without RTXCL (top) or with RTXCL (bottom).”
BackgroundInfluentialSubedi, S., Guntipally, M., Suwal, N., Thapa, R., Bashyal, S., Panth, N., Gupta, G., MacLoughlin, R. J., Oliver, B. G. G., Dua, K., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102813 · Cited by 40
The tumor suppressor ING1 contributes to epigenetic control of cellular senescence
Abad, M., Moreno, A., Palacios, A., Narita, M., Blanco, F. J., Moreno‐Bueno, G., Narita, M., & Palmero, I. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00651.x · Cited by 43
“…of tumor or normal cells (Mantovani et al., 2008), but they can also promote senescence (Acosta et al., 2008; Coppe et al., 2008; Kuilman et al., 2008; Wajapeyee et al., 2008; Rodier et al., 2009) defining the so-called SASP or senescencemessaging secretome (SMS) (Kuilman & Peeper, 2009).”
BackgroundInfluentialSenescence-Inflammatory Regulation of Reparative Cellular Reprogramming in Aging and Cancer
Menéndez, J. A., & Alarcón, T. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00049 · Cited by 34
“…as MMP3, growth factors such as HGF and TGFβ, inflammatory chemokines such as CCL2 and CLL11, and prominent proinflammatory cytokines such as IL1α/β, IL-6, and IL-8 (Coppé et al., 2008; Kuilman and Peeper, 2009; Orjalo et al., 2009; Rodier et al., 2009; Gross et al., 2012; Acosta et al., 2013).”
BackgroundSenescent cells and SASP in cancer microenvironment: New approaches in cancer therapy
Özdemir, A., Demir, Y. D. Ş., Yeşilyurt, Z. E., & Ark, M. (2022) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2022.10.002 · Cited by 36
Pramotton, F. M., Spitz, S., & Kamm, R. D. (2024) · Advanced Science · doi:10.1002/advs.202403892 · Cited by 39
Stress induced premature senescence: a new culprit in ovarian tumorigenesis?
Raghuram, G. V., & Mishra, P. K. (2014) · PubMed Central · Cited by 41
Ilie, O., Ciobica, A. S., Riga, S., Dhunna, N., McKenna, J., Mavroudis, I. A., Doroftei, B., Ciobanu, A. M., & Riga, D. (2020) · Medicina · doi:10.3390/medicina56110626 · Cited by 40
Macià, A., Vaquero, M., Gou-Fàbregas, M., Castelblanco, E., Valdivielso, J. M., Anerillas, C., Mauricio, D., Matías‐Guiu, X., Ribera, J., & Encinas, M. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.161 · Cited by 37
Removing all obstacles: A critical role for p53 in promoting tissue renewal
Schoppy, D. W., Ruzankina, Y., & Brown, E. J. (2010) · Cell Cycle · doi:10.4161/cc.9.7.11194 · Cited by 32
Maarouf, A., Boissard, A., Henry, C., Leman, G., Coqueret, O., Guette, C., & Lelièvre, E. (2021) · International Journal of Oncology · doi:10.3892/ijo.2021.5295 · Cited by 37
“Furthermore, senescent cells present specific hallmarks, such as DNA damage, that can be revealed by γH2Ax staining, the Senescence‐Associated Secretory Phenotype, and a compaction of proliferative genes termed Senescence‐Associated Heterochromatin Foci (4).”
BackgroundSenescence of Hepatic Stellate Cells by Specific Delivery of Manganese for Limiting Liver Fibrosis
Gu, L., Zhao, C., Wang, Y., Wang, C., Yin, X., Ye, Q., Liu, Y., Zou, X., Wang, L., Zhuge, Y., et al. (2024) · Nano Letters · doi:10.1021/acs.nanolett.3c03689 · Cited by 36
Heß, J., Unger, K., Orth, M., Schötz, U., Schüttrumpf, L., Zangen, V., Gimenez-Aznar, I., Michna, A., Schneider, L., Stamp, R., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.11.014 · Cited by 34
Lorda-Diez, C. I., Solis‐Mancilla, M. E., Sánchez–Fernández, C., García‐Porrero, J. A., Hurlé, J. M., & Montero, J. A. (2019) · Journal of Anatomy · doi:10.1111/joa.12972 · Cited by 32
“Some of these components are well known regulators of heart development, e.g. transforming growth factor b (TGFbs) members (Molin et al. 2003), but they are also well-characterized SASP components in many other systems (Kuilman & Peeper, 2009).”
BackgroundNano-Based Theranostic Tools for the Detection and Elimination of Senescent Cells
Adamczyk‐Grochala, J., & Lewińska, A. (2020) · Cells · doi:10.3390/cells9122659 · Cited by 32
“Abbreviations 17-AAG tanespimycin 17-DMAG alvespimycin AKT protein kinase B AMPK AMP-activated protein kinase B2M Beta-2 microglobulin Bcl-2 B cell lymphoma 2 family BETd BET family protein degrader CAR Chimeric antigen receptor CCL-16 Monotactin-1 CDKI Cyclin-dependent kinase inhibitor CS Cellular senescence DAMPs Da…”
BackgroundInfluentialZhang, N., Ji, J., Zhou, D., Liu, X., Zhang, X., Liu, Y., Xiang, W., Wang, M., Zhang, L., Wang, G., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020849 · Cited by 33
“Cell senescence, an irreversible state of cell proliferation, is an important cytological mechanism for body development and for the prevention of cancer [9,10].”
BackgroundSerrano, M. (2011) · Nature · doi:10.1038/479481a · Cited by 30
Lee, I., Park, C., & Kang, W. K. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0511 · Cited by 34
XPO7 is a tumor suppressor regulating p21CIP1-dependent senescence
Innes, A. J., Sun, B., Wagner, V., Brookes, S., McHugh, D., Pombo, J., Porreca, R. M., Dharmalingam, G., Vernia, S., Zuber, J., et al. (2021) · Genes & Development · doi:10.1101/gad.343269.120 · Cited by 30
“OIS occurs in premalignant lesions and limits tumorigenesis by arresting preneoplastic cells (Collado et al. 2005) and activating SASP-dependent”
BackgroundWang, J., Zhang, M., & Wang, H. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00284 · Cited by 35
Insights into 4E-BP1 and p53 mediated regulation of accelerated cell senescence
Chao, S. K., Horwitz, S. B., & McDaid, H. M. (2011) · Oncotarget · doi:10.18632/oncotarget.221 · Cited by 33
“Therefore, the tumor suppressive potential of senescence induction as a therapeutic strategy is limited by the concern that senescent cells may not be effectively cleared [27, 28, 31, 32].”
BackgroundRuan, J., Liao, Y., Lua, I., Li, M.-H., Hsu, C.-Y., & Chen, J. H. (2012) · Breast Cancer Research · doi:10.1186/bcr3226 · Cited by 33
Kamata, T., Jin, H., Giblett, S. M., PATEL, B., Patel, F., Foster, C., & Pritchard, C. A. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404838 · Cited by 34
“The tumour cells were identified to secrete a number of factors, although senescence-associated secretory proteins (SASPs) previously identified (Kuilman & Peeper, 2009) were not detected within our data set (Supplementary Table S2).”
Odeh, A., Dronina, M. A., Domankevich, V., Shams, I., & Manov, I. (2019) · Aging Cell · doi:10.1111/acel.13045 · Cited by 32
“Ten years have passed since senescence‐associated secretory phe‐ notype (SASP), a complex of predominantly pro‐inflammatory fac‐ tors secreted by aging cells, was first described (Coppe et al., 2008; Kuilman & Peeper, 2009).”
BackgroundTumor Milieu Controlled by RB Tumor Suppressor
Kitajima, S., Li, F., & Takahashi, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072450 · Cited by 31
“Interestingly, cytokines induced during SASP largely overlap with those that are upregulated following the treatment of CDK4/6 inhibitors.”
BackgroundAcid ceramidase promotes senescent cell survival
Munk, R. B., Anerillas, C., Rossi, M. S., Tsitsipatis, D., Martindale, J. L., Herman, A. B., Yang, J., Roberts, J. A., Varma, V. R., Pandey, P. R., et al. (2021) · Aging · doi:10.18632/aging.203170 · Cited by 34
“Although senescent cells do not divide, they remain metabolically active [5, 6]; this metabolic profile includes enhanced lysosomal activity associated with both growth arrest and a senescenceassociated secretory phenotype (SASP), whereby many proteins are secreted, including interleukin (IL) 6 and IL8 [7, 8].”
BackgroundHino, Y., Nagaoka, K., Oki, S., Etoh, K., Hino, S., & Nakao, M. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac735 · Cited by 32
“Senescent cells have been found to cause mitochondrial dysfunction, either activation or decline, and a proinflammatory program referred to as the senescence-associated secretory phenotype (SASP) (64,65).”
Ricci, F., Fratelli, M., Guffanti, F., Porcu, L., Spriano, F., Dell’Anna, T., Fruscio, R., & Damia, G. L. M. (2016) · Oncotarget · doi:10.18632/oncotarget.7465 · Cited by 31
“IGFBP4 is an important senescence-inducing factor in mesenchymalstem cells (MCS), reducing cell growth and is associated with a lower DNA-damage response and less nuclear phospho/activated-ERK in senescent than young MSCs [22].”
BackgroundAging promotes neoplastic disease through effects on the tissue microenvironment
Marongiu, F., Serra, M. P., Doratiotto, S., Sini, M., Fanti, M., Cadoni, E., Serra, M., & Laconi, E. (2016) · Aging · doi:10.18632/aging.101128 · Cited by 30
“This concept has been specifically linked to the peculiar secretory phenotype of senescent cells, SASP, which includes cytokines, proteases and growth factors, among others, and can profoundly impact the biological response of the surrounding tissue [13,14,24-27].”
BackgroundSenolytics: charting a new course or enhancing existing anti-tumor therapies?
Czajkowski, K., Herbet, M., Murias, M., & Piątkowska‐Chmiel, I. (2024) · Cellular Oncology · doi:10.1007/s13402-024-01018-5 · Cited by 41
“The senescence-associated secretory phenotype, also known as the senescence-messaging secretome, functions as a collection of proteins released by senescence cells into their microenvironment, serving as a key marker of cellular aging [ 32 , 33 ].”
Drug Tolerance to EGFR Tyrosine Kinase Inhibitors in Lung Cancers with EGFR Mutations
Suda, K., & Mitsudomi, T. (2021) · Cells · doi:10.3390/cells10071590 · Cited by 32
“Senescent cells communicate with neighboring cells through numerous secretory factors such as inflammatory cytokines, chemokines, and growth factors (senescence-associated secretory phenotype (SASP)) [48].”
BackgroundRelationship between Obesity, Gut Microbiome and Hepatocellular Carcinoma Development
Hara, E. (2015) · Digestive Diseases · doi:10.1159/000371679 · Cited by 33
Hornsby, P. J. (2009) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-009-0723-6 · Cited by 29
“A third is the intermediate role of cytokines that have an autocrine/paracrine function in maintaining senescence [ 40 , 59].”
BackgroundInfluentialMicroRNA and Senescence: The Senectome, Integration and Distributed Control
Bilsland, A. E., Revie, J., & Keith, W. N. (2013) · Critical Reviews in Oncogenesis · doi:10.1615/critrevoncog.2013007197 · Cited by 29
Barriers to the Preclinical Development of Therapeutics that Target Aging Mechanisms: Table 1.
Burd, C. E., Gill, M. S., Niedernhofer, L. J., Robbins, P. D., Austad, S. N., Barzilai, N., & Kirkland, J. L. (2016) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glw112 · Cited by 28
The role of cellular senescence in cardiovascular disease
Xu, C., Qiu, Z., Guo, Q., Huang, Y., Zhao, Y., & Zhao, R. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02720-5 · Cited by 37
“…cycle arrest, oxidative damage, up-regulation of the BCL-2 family of anti-apoptotic proteins, alterations in cellular morphology, nuclear senescence-associated heterochromatin foci (SAHF), senescence-associated secretory phenotype (SASP), metabolic changes, DNA damage response [15, 17, 18] (Fig.”
The Intricate Interplay between Mechanisms Underlying Aging and Cancer
Piano, A., & Titorenko, V. I. (2014) · Aging and Disease · doi:10.14336/ad.2014.0209 · Cited by 30
“Such late-response SASP/SMS protein components as the pro-inflammatory cytokines IL-6 and IL-8, chemokine/growth-related oncogene GROα, chemokine ligands (other than IL-8 and GROα) of the CXCR-2/IL8RB receptor, insulin-like growth factor binding protein IGFBP-7, and plasminogen activator inhibitor PAI-1 reinforce the…”
BackgroundInfluentialThorin‐Trescases, N., Labbé, P., Mury, P., Lambert, M., & Thorin, É. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212232 · Cited by 31
“The concept of a senescent secretory phenotype was then proposed by the Campisi group [83], known as the SASP [12,13].”
BackgroundRamírez, R., Ceprián, N., Figuer, A., Valera, G., Bodega, G., Alique, M., & Carracedo, J. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12020215 · Cited by 31
“SASP proteins transported in EVs could also be distinct for each senescent phenotype.”
BackgroundInfluentialAntagonistic TSC22D1 variants control BRAFE600‐induced senescence
Cornelia, H.-H., van Doorn, R., Vogel, C., Germann, M., Cecchini, M. G., Verdegaal, E. M. E., & Peeper, D. S. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.95 · Cited by 31
“Thus, secreted factors are important mediators of both oncogeneinduced and replicative senescence, collectively termed as the senescence-messaging secretome (SMS) (Kuilman and Peeper, 2009).”
BackgroundSelf-citationLi, D., Fu, J., Du, M., Zhang, H., Li, L., Cen, J., Li, W., Chen, X., Lin, Y., Conway, E. M., et al. (2016) · Hepatology · doi:10.1002/hep.28637 · Cited by 28
“One of the key players in regulating cancer-associated immune responses is cellular senescence.((5,6))”
The Role of Kinase Modulators in Cellular Senescence for Use in Cancer Treatment
Lee, C. W., Baek, J., & Han, S. (2017) · Molecules · doi:10.3390/molecules22091411 · Cited by 31
“While OIS is considered to be a tumor suppression mechanism [91], pro-tumorigenic molecules are also secreted by senescent cells, manifesting the senescence-associated secretory phenotype (SASP) [92].”
BackgroundA Transient Pseudosenescent Secretome Promotes Tumor Growth after Antiangiogenic Therapy Withdrawal
Mastri, M., Tracz, A., Lee, C. R., Dolan, M., Attwood, K., Christensen, J. G., Liu, S., & Ebos, J. M. L. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.12.017 · Cited by 28
“…secretome (SMS), therapy-induced secretomes (TISs), and acute stress-associated phenotypes (ASAPs) (Coppé et al., 2008, 2010; Rodier et al., 2009; Bent et al., 2016; Kuilman et al., 2008; Obenauf et al., 2015; Acosta et al., 2008; Kuilman and Peeper, 2009; Pribluda et al., 2013).”
Two Functionally Distinct Isoforms of TL1A (TNFSF15) Generated by Differential Ectodomain Shedding
Mück, C., Herndler‐Brandstetter, D., Mičutková, L., Grubeck‐Loebenstein, B., & Jansen‐Dürr, P. (2010) · The Journals of Gerontology Series A · doi:10.1093/gerona/glq129 · Cited by 28
“The secretome of senescent cells, referred to as the senescence-associated secretory phenotype (11) or the senescence-messaging secretome (12), is complex and, besides cytokines and chemokines (13), includes other factors that are involved in senescence-associated proliferation arrest, such as insulin-like growth fact…”
BackgroundGiunta, S., Wei, Y., Xu, K., & Xia, S. (2022) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13686 · Cited by 27
“Therefore, inflammaging is also a privileged target to combat age-related diseases as a whole and not one by one.(43,44)”
BackgroundKwon, I., Kim, J., Rhee, D., Kim, B.-O., & Pyo, S. (2017) · Toxicon · doi:10.1016/j.toxicon.2017.02.017 · Cited by 30
“PAI-1, phosphor-p53, p53, p21, p16, CDK2, SIRT-1, phosphor-Rb, phosphor-SIRT-1, p65, ERK1/2, phosphor-ERK1/2, p38, phosphor-p38, JNK, phosphor-JNK and bactin antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA).”
BackgroundInfluentialSong, J., & Bae, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22010406 · Cited by 32
“SASP is associated with the expression of various cytokines and chemokines, including interleukin (IL)-1α/β, IL-6, IL-8, growth factors, such as epidermal growth factor and vascular endothelial growth factor, and matrix metalloproteinases (MMPs), such as MMP3 and MMP9 [4,5].”
BackgroundTherapeutic Potential of EWSR1–FLI1 Inactivation by CRISPR/Cas9 in Ewing Sarcoma
Cervera, S. T., Rodriguez‐Martin, C., Fernández-Tabanera, E., de Mera, R. M. M.-F., Morin, M., Fernández-Peñalver, S., Iranzo-Martínez, M., Amhih-Cardenas, J., García‐García, L., González‐González, L., et al. (2021) · Cancers · doi:10.3390/cancers13153783 · Cited by 32
Rack1 is essential for corticogenesis by preventing p21-dependent senescence in neural stem cells
Zhu, Q., Chen, L., Li, Y., Huang, M.-H., Shao, J., Li, S., Cheng, J., Yang, H., Wu, Y., Zhang, J., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109639 · Cited by 29
Li, T., Lu, H., Zhou, L., Jia, M., Zhang, L., Wu, H., Shan, L., & Efferth, T. (2021) · Cell Proliferation · doi:10.1111/cpr.13212 · Cited by 26
“SASP is the main characteristics of cellular senescence, containing specific proinflammatory and senescence messaging secretome.(70) The NF-κBactivated SASP factors, such as IL-6, IL-8 and MMPs, induce paracrine DNA damage, chronic inflammation and senescence of healthy neighbouring cells, resulting in acceleration of…”
BackgroundSecretory function of autophagy in innate immune cells
Bhattacharya, A., Prakash, Y. S., & Eissa, N. T. (2014) · Cellular Microbiology · doi:10.1111/cmi.12365 · Cited by 29
“Oncogene-induced senescence (OIS), an antiproliferative response induced by oncogene activation or inactivation of tumour suppressor genes, is characterized by an arrest of cell proliferation and global changes in secretion (Kuilman and Peeper, 2009).”
BackgroundStåhl, S., Kaminskyy, V. O., Efazat, G., Vaculová, A. H., Rodrı́guez-Nieto, S., Moshfegh, A., Lewensohn, R., Viktorsson, K., & Zhivotovsky, B. (2013) · Cell Death and Disease · doi:10.1038/cddis.2012.188 · Cited by 26
Vassilieva, I. O., Reshetnikova, G., Shatrova, A. N., Tsupkina, N. V., Харченко, М. В., Lp, A., Nikolsky, N. N., & Burova, E. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.01.163 · Cited by 31
Xie, J., Xu, X., Yin, P., Li, Y., Guo, H., Kujawa, S. A., Chakravarti, D., Bulun, S. E., Kim, J. J., & Wei, J. (2018) · Laboratory Investigation · doi:10.1038/s41374-018-0117-5 · Cited by 30
“factors, including interleukins, chemokines, growth factors, and inflammatory mediators, are pro-mitogenic, which can affect surrounding tumor cells [21, 22].”
BackgroundFountoulakis, N., Miyamoto, Y., Pavkov, M. E., Karalliedde, J. J., & Maltese, G. (2024) · Diabetic Medicine · doi:10.1111/dme.15464 · Cited by 31
The Two Faces of NF-κB Signaling in Cancer Development and Therapy
Klein, U., & Ghosh, S. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.10.026 · Cited by 29
Autophagy and PTEN in DNA damage-induced senescence
Sharma, A., & Almasan, A. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.01.006 · Cited by 29
Manouchehri, N., Salinas, V. H., Yeganeh, N. R., Pitt, D., Hussain, R. Z., & Stüve, O. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.854390 · Cited by 28
Czarnecka‐Herok, J., Śliwińska, M. A., Herok, M., Targońska, A., Strzeszewska, A., Bojko, A., Wolny, A., Mosieniak, G., & Sikora, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158288 · Cited by 29
“The cytokines and other molecules secreted by senescent cells profoundly affect the cellular and tissue microenvironment and exert mostly, but not exclusively, deleterious effects, including pro-cancerogenic ones [3].”
BackgroundInflammageing and Cardiovascular System: Focus on Cardiokines and Cardiac-Specific Biomarkers
Perrone, M. A., Aimo, A., Bernardini, S., & Clerico, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010844 · Cited by 35
RAB7 counteracts PI3K-driven macropinocytosis activated at early stages of melanoma development
Alonso‐Curbelo, D., Osterloh, L., Cañón, E., Calvo, T. G., Martínez-Herranz, R., Karras, P., Martínez, S., Riveiro‐Falkenbach, E., Romero, P. L. O., Rodríguez‐Peralto, J. L., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4055 · Cited by 27
“In fact, a defining feature of OIS (in melanocytes and other cell types) is the secretion of a plethora of cytokines, matrix remodelers and other factors, termed as the senescence-associated secretory phenotype (SASP), which together blunt oncogenic transformation [58].”
BackgroundLafferty-Whyte, K., Bilsland, A., Cairney, C. J., Hanley, L., Jamieson, N. B., Zaffaroni, N., Oien, K. A., Burns, S., Roffey, J., Boyd, S. M., et al. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-532 · Cited by 26
“To improve the understanding of senescence signalling it is becoming increasingly necessary to look beyond the expression of individual genes and at the larger signalling processes they are involved in. Previous studies up to now have looked at senescence in terms of the expression of individual biomarkers [ 11 ,18,20…”
InfluentialFra‐1 plays a critical role in angiotensin II—induced vascular senescence
Yang, D., Xiao, C., Long, F., Wu, W., Huang, M., Qu, L., Liu, X., & Zhu, Y. Z. (2019) · The FASEB Journal · doi:10.1096/fj.201801671rrrr · Cited by 28
“Existing evidence suggests that senescent ECs significantly contribute to age-related cardiovascular disease (11).”
Background
Metadata
- Authors
- Kuilman, T., & Peeper, D. S.
- Affiliations
- The Netherlands Cancer Institute (NL)
- Corresponding author
- Peeper, Daniel S.
- Venue
- Nature Reviews Cancer
- Published
- 2009-01-09
- Volume
- 9
- Issue
- 2
- Pages
- 81-94
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2005248738
- Cited by
- 909
- References
- 146
- Citations by year
- 2026: 25 · 2025: 46 · 2024: 46 · 2023: 48 · 2022: 54 · 2021: 73 · 2020: 62 · 2019: 43 · 2018: 63 · 2017: 56 · 2016: 60 · 2015: 53 · 2014: 68 · 2013: 55 · 2012: 47
- FWCI
- 5.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- KWF Kankerbestrijding
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- secreted factors, senescence-associated secretory phenotype, cancer protection
- MeSH terms
- Animals, Cell Communication, Humans, Neoplasms, Signal Transduction, Cellular Senescence, Tumor Suppressor Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.